News & Events
This just in
Expertise in all things FDA
Menu
Menu
Practices
Industries
FDA Regulatory Categories
Professionals
About Us
Contact Us
FDA Law Blog
News & Events
Search
Twitter
FDA Law Blog
News & Events
Twitter
Search
Author
Adrienne R. Lenz
Alan M. Kirschenbaum
Allyson B. Mullen
Andrew J. Hull
Anne K. Walsh
David C. Gibbons
Faraz Siddiqui
Frank J. Sasinowski
Gail H. Javitt
James E. Valentine
Jay W. Cormier
Jeffrey K. Shapiro
Jeffrey N. Gibbs
Jennifer M. Thomas
John R. Fleder
Karla Palmer
Kurt Karst
Lisa Harrington
Mark I. Schwartz
McKenzie E. Cato
Michael S Heesters
Michelle L. Butler
Mike Shumsky
Rachael Hunt
Ricardo Carvajal
Robert Dormer
Sara Koblitz
Serra Schlanger
Suchira Ghosh
Date
June 2021
May 2021
April 2021
March 2021
February 2021
January 2021
December 2020
November 2020
October 2020
September 2020
August 2020
July 2020
June 2020
May 2020
April 2020
March 2020
February 2020
January 2020
December 2019
November 2019
October 2019
September 2019
August 2019
July 2019
June 2019
May 2019
April 2019
March 2019
February 2019
January 2019
December 2018
November 2018
October 2018
September 2018
August 2018
July 2018
June 2018
May 2018
April 2018
March 2018
February 2018
January 2018
November 2017
October 2017
September 2017
August 2017
July 2017
June 2017
May 2017
April 2017
March 2017
February 2017
January 2017
December 2016
November 2016
October 2016
September 2016
August 2016
July 2016
June 2016
May 2016
April 2016
March 2016
February 2016
January 2016
November 2015
October 2015
September 2015
August 2015
July 2015
June 2015
May 2015
April 2015
March 2015
February 2015
January 2015
December 2014
November 2014
October 2014
September 2014
August 2014
July 2014
June 2014
May 2014
April 2014
March 2014
February 2014
January 2014
December 2013
November 2013
October 2013
September 2013
August 2013
July 2013
June 2013
May 2013
April 2013
March 2013
February 2013
January 2013
December 2012
November 2012
October 2012
September 2012
August 2012
July 2012
June 2012
May 2012
April 2012
March 2012
February 2012
January 2012
December 2011
November 2011
October 2011
September 2011
August 2011
July 2011
June 2011
May 2011
April 2011
March 2011
February 2011
January 2011
December 2010
November 2010
October 2010
September 2010
August 2010
July 2010
June 2010
May 2010
April 2010
March 2010
February 2010
January 2010
December 2009
November 2009
October 2009
September 2009
August 2009
July 2009
June 2009
May 2009
April 2009
March 2009
February 2009
January 2009
December 2008
November 2008
October 2008
September 2008
August 2008
July 2008
June 2008
May 2008
April 2008
March 2008
February 2008
January 2008
December 2007
November 2007
October 2007
September 2007
August 2007
July 2007
June 2007
May 2007
April 2007
March 2007
February 2007
January 2007
December 2006
November 2006
October 2006
September 2006
August 2006
July 2006
June 2006
May 2006
April 2006
March 2006
February 2006
January 2006
November 2005
October 2005
September 2005
August 2005
June 2005
May 2005
April 2005
March 2005
January 2005
November 2004
September 2004
July 2004
June 2004
January 2004
November 2003
October 2003
September 2003
June 2003
May 2003
February 2003
January 2003
September 2002
July 2002
June 2002
May 2002
January 2002
July 2001
May 2001
April 2001
February 2001
October 2000
April 2000
January 2000
November 1999
January 1999
January 1998
October 1997
January 1994
January 1991
July 1989
January 1984
Type
Events
News
Publications
Filter By
Practice
FDA Categories
Distribution & Dispensing
Enforcement & Litigation
Hatch-Waxman & Biosimilars
Labeling, Advertising & Promotion
Agriculture Producers
Animal Feed & Pet Foods
Biosimilars
Colors & Colorants
Combination Products
Compound Drug Products
Cosmetic Retailers
Cosmetics
Drugs & Biologics
Food & Dietary Supplement
Food Contact Materials
Gene Therapy
IVD/LDT
Meat & Poultry Products
Medical Devices
Tobacco Processors
Tobacco
Veterinary Drugs
view all
News & Publications
D.C. CIRCUIT CORRECTS FDA’S ABUSE OF DISCRETION IN DRUG VS. DEVICE DETERMINATION
June 9, 2021
Top Food and Drug Cases 2020 and Cases to Watch 2021
June 9, 2021
Top Food and Drug Cases 2020 and Cases to Watch 2021: GlaxoSmithKline LLC v. Teva Pharmaceuticals USA, Inc.
June 9, 2021
Pandemic Forces F.D.A. to Sharply Curtail Drug Company Inspections, The New York Times
March 9, 2021
Diagnostics at a Crossroads: Navigating IVD Regulation in a Changing Environment
February 23, 2021
Biden’s FDA Needs Course Corrections to Increase Covid-19 Testing
February 12, 2021
view all
Events
Deborah Livornese is speaking at FDLI's Regenerative Medicine: Regulatory, Legal, and Compliance Challenges for Cell and Gene Therapies Conference
June 8, 2021
Jeff Gibbs is speaking at FDLI Annual Conference: Exploring Advanced Topics in Food and Drug Law
May 19, 2021
Anne Walsh is speaking at FDLI Annual Conference: Exploring Advanced Topics in Food and Drug Law
May 18, 2021
Serra Schlanger is a panelist in a Webinar: Global Monitoring and Analytics
April 20, 2021
Allyson Mullen is speaking at AMDM's Annual IVD Regulatory Meeting
April 16, 2021
Expertise in all things FDA